Advanced search
Publication Cover
mAbs Volume 8, 2016 - Issue 2
Submit an article Journal homepage
1,157
Views
15
CrossRef citations to date
0
Altmetric
Short Communication

Incomplete target neutralization by the anti-cancer antibody rilotumumab

Sameer A. GreenallOncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, Hudson Institute of Medical Research, 27–31 Wright Street, Clayton, VIC 3168, Australia;Monash University, Wellington Parade, Clayton, VIC 3800, Australia;Biomedical Manufacturing Program, Commonwealth Scientific and Industrial Research Organisation, 343 Royal Parade, Parkville, VIC 3052, Australia
,
Timothy E. AdamsBiomedical Manufacturing Program, Commonwealth Scientific and Industrial Research Organisation, 343 Royal Parade, Parkville, VIC 3052, Australia
&
Terrance G. JohnsOncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, Hudson Institute of Medical Research, 27–31 Wright Street, Clayton, VIC 3168, Australia;Monash University, Wellington Parade, Clayton, VIC 3800, AustraliaCorrespondence[email protected]
Pages 246-252 | Received 05 Oct 2015, Accepted 15 Nov 2015, Published online: 18 Feb 2016

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

H. Kaspar Binz, Talitha R. Bakker, Douglas J. Phillips, Andreas Cornelius, Christof Zitt, Thomas Göttler, Gabriel Sigrist, Ulrike Fiedler, Savira Ekawardhani, Ignacio Dolado, Johan Abram Saliba, Gaby Tresch, Karl Proba & Michael T. Stumpp. (2017) Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate. mAbs 9:8, pages 1262-1269.
Read now

Articles from other publishers (14)

Selin Bicer, Nora Hutchinson, Emma Feldhake, Angela Nelson, Elisabeth Oliviero, Marcin Waligóra & Jonathan Kimmelman. (2023) Timing for First-in-Minor Clinical Trials of New Cancer Drugs. The Journal of Pediatrics 263, pages 113705.
Crossref
Takuro Matsuzawa, Masanobu Morita, Ai Shimane, Rina Otsuka, Yu Mei, Fumitoshi Irie, Yu Yamaguchi, Kazuhiko Yanai & Takeo Yoshikawa. (2021) Heparan sulfate promotes differentiation of white adipocytes to maintain insulin sensitivity and glucose homeostasis. Journal of Biological Chemistry 297:3, pages 101006.
Crossref
Amanda Rose Khater & Tamara Abou-Antoun. (2021) Mesenchymal Epithelial Transition Factor Signaling in Pediatric Nervous System Tumors: Implications for Malignancy and Cancer Stem Cell Enrichment. Frontiers in Cell and Developmental Biology 9.
Crossref
Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Romano C. Pirola, Jeremy S. Wilson & Minoti V. Apte. (2020) Targeting HGF/c-MET Axis in Pancreatic Cancer. International Journal of Molecular Sciences 21:23, pages 9170.
Crossref
A.M. Kopylov, E.G. Zavyalova, G.V. Pavlova & I.N. Pronin. (2020) Theranostics for glioblastoma with monoclonal antibodies to the epidermal growth factor receptor. Voprosy neirokhirurgii imeni N.N. Burdenko 84:3, pages 113.
Crossref
Seung Tae KimJung Yong HongSe Hoon ParkJoon Oh ParkYoung Whan ParkNeunggyu ParkHukeun LeeSung Hee HongSong-Jae LeeSeong-Won SongKyung KimYoung Suk ParkHo Yeong LimWon Ki KangDo-Hyun NamJeong-Won LeeKeunchil ParkKyoung-Mee KimJeeyun Lee. (2020) First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients. Therapeutic Advances in Medical Oncology 12, pages 175883592092679.
Crossref
Hardy-Werbin, Rey-Vergara, Galindo-Campos, Moliner & Arriola. (2019) MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside. Cancers 11:10, pages 1404.
Crossref
Cristina Moldovan Loomis, Benjamin Dutzar, Ethan W. Ojala, Lee Hendrix, Charlie Karasek, Michelle Scalley-Kim, Jenny Mulligan, Pei Fan, Jens Billgren, Vanessa Rubin, Heidi Boshaw, Gayle Kwon, Sam Marzolf, Erica Stewart, David Jurchen, Susan M. Pederson, Lisa Perrino McCulloch, Brian Baker, Roger K. Cady, John A. Latham, Dan Allison & Leon F. Garcia-Martinez. (2019) Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide. Journal of Pharmacology and Experimental Therapeutics 369:1, pages 26-36.
Crossref
Dinuka M. De Silva, Arpita Roy & Donald P. Bottaro. 2018. Extracellular Targeting of Cell Signaling in Cancer. Extracellular Targeting of Cell Signaling in Cancer 155 198 .
John Kaczmar & Tim N. Beck. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 63 88 .
Ulrike Fiedler, Savira Ekawardhani, Andreas Cornelius, Pat Gilboy, Talitha R. Bakker, Ignacio Dolado, Michael T. Stumpp & Keith M. Dawson. (2017) MP0250, a VEGF and HGF neutralizing DARPin® molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models. Oncotarget 8:58, pages 98371-98383.
Crossref
Vegard Tjomsland, Monica Aasrum, Thoralf Christoffersen & Ivar P Gladhaug. (2017) Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells. Oncotarget 8:42, pages 71672-71684.
Crossref
Hyori Kim, Sung Hee Hong, Jung Yong Kim, In-Chull Kim, Young-Whan Park, Song-Jae Lee, Seong-Won Song, Jung Ju Kim, Gunwoo Park, Tae Min Kim, Yun-Hee Kim, Jong Bae Park, Junho Chung & In-Hoo Kim. (2017) Preclinical development of a humanized neutralizing antibody targeting HGF. Experimental & Molecular Medicine 49:3, pages e309-e309.
Crossref
Yanni Zhang, Zhiqiang Du & Mingqiang Zhang. (2016) Biomarker development in MET-targeted therapy. Oncotarget 7:24, pages 37370-37389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.